Archive for February 2016

Can the Air Canada deal be the beginning of Bombadier’s comeback?

By Gediminas Velutis Bombardier, the Canadian multinational aerospace and transportation company has received its first order in the last 16 months for its CSeries jets from Air Canada. The airline company has ordered 45 jets with an option for 30 more CSeries aircraft for $3.8 billion. The announcement sent Bombardier’s share price up by 30…

Read More

Who owns the sun?

By Chiara Ponte In the past decades, solar power has always been at the periphery of the utility sector: panels had been installed thanks to government subsidy activities and adopted only by early user investors. Nowadays, solar power is rocking (even if in a relative low base) while the fossil fuel industry is trying to…

Read More

Arcelor Mittal – melting away?

By Julian Flüß ArcelorMittal, the Luxembourg based, world largest steel manufacturer struggles to satisfy markets’ and investors’ needs. With a lacklustre performance of an astonishing 69 per cent one-year drop and a record annual net loss of more than 7 billion Dollars, the company fell short of analysts’, as well as its shareholders, expectations. The…

Read More

Card Factory: Greeting an inevitable demise?

Jemima Atkins Card Factory Plc (CARD.L) is the UK’s leading retailer of low-value greeting cards and associated gifts. The Group has 814 stores across the UK, as well as two branded websites selling standard and personalised cards and gifts. The company is showing strong performance, with a total sales growth of 8.1% in the 11…

Read More

Excellent results shown in breakthrough cancer treatment

Christophe Martin Brawand A breakthrough procedure that employs the body’s immune response has shown excellent results in clinical trials, for the treatment of advanced forms of blood cancer. The trials were conducted at the Fred Hutchinson Cancer Research Center in Seattle. The procedure employs a form of genetic engineering, to reprogram T-cells to eliminate tumours.…

Read More

Biosimilars: The new threats on the block

Anupurba Roy Biological drugs are at the cutting edge of medical technology. They involve using living cells, and organic matter such as hormones, blood components and antibodies coupled with recombinant DNA technology to manufacture focussed cures for diseases such as cancer and rheumatoid arthritis. It is their specific nature that also makes them free of…

Read More

3D-Printed organs anyone?

Josh Moss According to Engadget, a technology news outlet, doctors at the Wake Forest Institute for Regenerative Medicine announced yesterday that they have managed to 3D print “living” tissue and organs that functioned properly when implanted in animals. The new printer developed over the past decade is called the Integrated Tissue and Organ Printing System…

Read More

Advertising in the Superbowl

By Thomas Hardwick This Sunday, at 23:30 GMT the Carolina Panthers will face off against the Denver Broncos in ‘Super Bowl 50’, America’s most watched and eagerly anticipated sporting event. An estimated 120 million people are expected to watch the game, with the day being heralded an unofficial public holiday in The United States. CBS,…

Read More